| 0.3 |
1.5 |
GO:0072658 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.2 |
0.7 |
GO:0070563 |
negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.2 |
0.6 |
GO:1990654 |
sebum secreting cell proliferation(GO:1990654) |
| 0.2 |
0.6 |
GO:0014016 |
neuroblast differentiation(GO:0014016) |
| 0.2 |
1.0 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.2 |
0.6 |
GO:0000270 |
peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.2 |
1.1 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.2 |
1.2 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.1 |
1.3 |
GO:0043305 |
negative regulation of mast cell degranulation(GO:0043305) |
| 0.1 |
1.1 |
GO:1902202 |
regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.1 |
5.8 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.4 |
GO:0003331 |
regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.1 |
0.7 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.1 |
0.4 |
GO:1901876 |
regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.1 |
0.4 |
GO:1903045 |
neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
| 0.1 |
0.3 |
GO:0098507 |
polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.1 |
1.8 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 |
2.3 |
GO:0006068 |
ethanol catabolic process(GO:0006068) |
| 0.1 |
0.5 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.1 |
0.3 |
GO:1904428 |
negative regulation of tubulin deacetylation(GO:1904428) |
| 0.1 |
0.3 |
GO:0009441 |
glycolate metabolic process(GO:0009441) |
| 0.1 |
0.9 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.1 |
0.8 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.1 |
0.3 |
GO:0071418 |
cellular response to amine stimulus(GO:0071418) |
| 0.1 |
0.2 |
GO:0009913 |
epidermal cell differentiation(GO:0009913) |
| 0.1 |
0.4 |
GO:0006203 |
dGTP catabolic process(GO:0006203) |
| 0.1 |
0.2 |
GO:1901994 |
negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.1 |
0.1 |
GO:0003356 |
regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
| 0.1 |
0.2 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.1 |
0.4 |
GO:0071047 |
nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
| 0.1 |
0.3 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.1 |
0.3 |
GO:0018312 |
peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.1 |
0.2 |
GO:0070175 |
positive regulation of enamel mineralization(GO:0070175) |
| 0.1 |
0.1 |
GO:1901660 |
calcium ion export(GO:1901660) |
| 0.1 |
0.1 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 |
0.6 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.1 |
2.0 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.1 |
0.2 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.1 |
0.4 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.1 |
0.3 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.1 |
0.2 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.1 |
0.6 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 |
0.3 |
GO:0052214 |
multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
| 0.1 |
0.2 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.1 |
0.3 |
GO:0035544 |
negative regulation of SNARE complex assembly(GO:0035544) |
| 0.1 |
0.2 |
GO:1901076 |
positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 0.1 |
0.6 |
GO:0090063 |
positive regulation of microtubule nucleation(GO:0090063) |
| 0.1 |
0.1 |
GO:0044111 |
development involved in symbiotic interaction(GO:0044111) |
| 0.1 |
0.4 |
GO:0014805 |
smooth muscle adaptation(GO:0014805) |
| 0.1 |
0.4 |
GO:1903435 |
positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.1 |
0.2 |
GO:0060516 |
primary prostatic bud elongation(GO:0060516) |
| 0.1 |
0.2 |
GO:1902523 |
positive regulation of protein K63-linked ubiquitination(GO:1902523) |
| 0.1 |
0.2 |
GO:0090410 |
malonate catabolic process(GO:0090410) |
| 0.1 |
0.3 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.1 |
0.2 |
GO:1903926 |
signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.1 |
0.6 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 |
0.6 |
GO:0097338 |
response to clozapine(GO:0097338) |
| 0.1 |
0.1 |
GO:0090317 |
negative regulation of intracellular protein transport(GO:0090317) |
| 0.1 |
0.8 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.1 |
0.2 |
GO:0018969 |
thiocyanate metabolic process(GO:0018969) |
| 0.1 |
0.2 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 |
0.2 |
GO:0090294 |
nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
| 0.1 |
0.4 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 0.1 |
0.3 |
GO:1904448 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.0 |
0.1 |
GO:0070408 |
carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
| 0.0 |
0.1 |
GO:1904798 |
positive regulation of core promoter binding(GO:1904798) |
| 0.0 |
0.2 |
GO:0033140 |
negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.0 |
0.2 |
GO:0008204 |
ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.0 |
1.0 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.0 |
0.7 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.1 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.0 |
0.3 |
GO:0002729 |
positive regulation of natural killer cell cytokine production(GO:0002729) |
| 0.0 |
0.1 |
GO:0090291 |
negative regulation of osteoclast proliferation(GO:0090291) |
| 0.0 |
0.3 |
GO:0097676 |
histone H3-K36 dimethylation(GO:0097676) |
| 0.0 |
0.3 |
GO:1903490 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.0 |
0.1 |
GO:0002188 |
translation reinitiation(GO:0002188) |
| 0.0 |
0.1 |
GO:0048003 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.0 |
0.3 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 0.0 |
0.2 |
GO:2000002 |
negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.0 |
0.2 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.0 |
0.2 |
GO:0032072 |
plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.0 |
0.1 |
GO:0071373 |
cellular response to luteinizing hormone stimulus(GO:0071373) |
| 0.0 |
0.1 |
GO:0070426 |
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.0 |
0.3 |
GO:0010752 |
regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 0.0 |
0.2 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.0 |
0.2 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.0 |
0.1 |
GO:0051311 |
meiotic metaphase I plate congression(GO:0043060) meiotic spindle midzone assembly(GO:0051257) meiotic metaphase plate congression(GO:0051311) |
| 0.0 |
0.2 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 0.0 |
0.4 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.0 |
0.6 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.0 |
0.3 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.0 |
0.1 |
GO:0072684 |
mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.0 |
0.2 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.0 |
0.2 |
GO:0071283 |
cellular response to iron(III) ion(GO:0071283) |
| 0.0 |
0.2 |
GO:0072255 |
metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
| 0.0 |
0.2 |
GO:0038108 |
negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.0 |
0.1 |
GO:0000961 |
negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.0 |
0.4 |
GO:0086024 |
adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.0 |
0.2 |
GO:1901078 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.0 |
0.2 |
GO:0070171 |
negative regulation of tooth mineralization(GO:0070171) |
| 0.0 |
0.1 |
GO:0035623 |
renal glucose absorption(GO:0035623) |
| 0.0 |
0.3 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.0 |
0.1 |
GO:0043091 |
L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
| 0.0 |
0.3 |
GO:0035166 |
post-embryonic hemopoiesis(GO:0035166) |
| 0.0 |
0.2 |
GO:0007468 |
regulation of rhodopsin gene expression(GO:0007468) |
| 0.0 |
0.1 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.0 |
0.1 |
GO:2001160 |
regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.0 |
0.3 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.0 |
0.1 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.0 |
0.2 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.0 |
0.4 |
GO:0070294 |
renal sodium ion absorption(GO:0070294) |
| 0.0 |
0.1 |
GO:0001878 |
response to yeast(GO:0001878) |
| 0.0 |
0.1 |
GO:0060382 |
regulation of DNA strand elongation(GO:0060382) |
| 0.0 |
0.1 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.0 |
0.2 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.0 |
0.1 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.0 |
0.1 |
GO:0060988 |
lipid tube assembly(GO:0060988) |
| 0.0 |
0.2 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.0 |
0.2 |
GO:0010513 |
positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.0 |
0.8 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.0 |
0.1 |
GO:2001247 |
positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.0 |
0.2 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.0 |
0.1 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.0 |
0.1 |
GO:0019860 |
uracil metabolic process(GO:0019860) intestinal epithelial cell maturation(GO:0060574) |
| 0.0 |
0.2 |
GO:0001865 |
NK T cell differentiation(GO:0001865) |
| 0.0 |
0.6 |
GO:0008212 |
mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.0 |
0.1 |
GO:1903542 |
negative regulation of exosomal secretion(GO:1903542) |
| 0.0 |
0.2 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.0 |
0.1 |
GO:0071790 |
spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.0 |
0.1 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.0 |
0.2 |
GO:0009407 |
toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 0.0 |
0.4 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.0 |
0.6 |
GO:0045636 |
positive regulation of melanocyte differentiation(GO:0045636) |
| 0.0 |
0.2 |
GO:1902956 |
regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
| 0.0 |
0.1 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.0 |
0.1 |
GO:1901074 |
regulation of engulfment of apoptotic cell(GO:1901074) |
| 0.0 |
0.1 |
GO:0007499 |
ectoderm and mesoderm interaction(GO:0007499) female genitalia morphogenesis(GO:0048807) |
| 0.0 |
0.1 |
GO:1904823 |
pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.0 |
0.3 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.0 |
0.1 |
GO:0060221 |
retinal rod cell differentiation(GO:0060221) |
| 0.0 |
0.2 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.0 |
0.1 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.0 |
0.1 |
GO:1904481 |
response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.0 |
0.2 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.0 |
0.1 |
GO:1902299 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.0 |
0.1 |
GO:0035038 |
female pronucleus assembly(GO:0035038) |
| 0.0 |
0.1 |
GO:1903201 |
cell death in response to oxidative stress(GO:0036473) regulation of oxidative stress-induced cell death(GO:1903201) |
| 0.0 |
0.5 |
GO:0098828 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.0 |
0.5 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
0.1 |
GO:1902080 |
regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.0 |
0.1 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.0 |
0.3 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.0 |
0.3 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.0 |
0.1 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.0 |
0.1 |
GO:0060018 |
astrocyte fate commitment(GO:0060018) |
| 0.0 |
0.1 |
GO:0019303 |
D-ribose catabolic process(GO:0019303) |
| 0.0 |
0.1 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.0 |
0.2 |
GO:2001183 |
negative regulation of interleukin-12 secretion(GO:2001183) |
| 0.0 |
0.7 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.0 |
0.2 |
GO:0010767 |
regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 0.0 |
0.2 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.0 |
0.2 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.0 |
0.1 |
GO:0007098 |
centrosome cycle(GO:0007098) |
| 0.0 |
0.1 |
GO:1901143 |
insulin catabolic process(GO:1901143) |
| 0.0 |
0.1 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.0 |
0.2 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.0 |
0.1 |
GO:0006781 |
succinyl-CoA pathway(GO:0006781) |
| 0.0 |
0.1 |
GO:1900104 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.0 |
0.2 |
GO:0015887 |
biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.0 |
0.1 |
GO:0097680 |
double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.0 |
0.2 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.0 |
0.2 |
GO:1903826 |
arginine transmembrane transport(GO:1903826) |
| 0.0 |
0.1 |
GO:0051029 |
rRNA transport(GO:0051029) |
| 0.0 |
0.1 |
GO:0021510 |
spinal cord development(GO:0021510) |
| 0.0 |
0.7 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.0 |
0.2 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.0 |
0.2 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.0 |
0.1 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 |
0.0 |
GO:1901856 |
negative regulation of cellular respiration(GO:1901856) |
| 0.0 |
0.0 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.0 |
0.3 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.0 |
0.3 |
GO:0034465 |
response to carbon monoxide(GO:0034465) |
| 0.0 |
0.1 |
GO:0098884 |
postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.0 |
0.2 |
GO:0060125 |
negative regulation of growth hormone secretion(GO:0060125) |
| 0.0 |
0.1 |
GO:0009258 |
10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.0 |
0.4 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.0 |
0.0 |
GO:0009149 |
pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.0 |
0.6 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.0 |
0.1 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.0 |
0.1 |
GO:0033561 |
regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
| 0.0 |
0.2 |
GO:0046078 |
pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
| 0.0 |
0.1 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.0 |
0.1 |
GO:0050758 |
thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.0 |
0.0 |
GO:0002638 |
negative regulation of immunoglobulin production(GO:0002638) |
| 0.0 |
0.2 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.0 |
0.4 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.0 |
0.1 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.0 |
0.3 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.0 |
0.9 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.0 |
0.1 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.0 |
0.1 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.0 |
0.1 |
GO:0048075 |
positive regulation of eye pigmentation(GO:0048075) |
| 0.0 |
0.1 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.0 |
0.3 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.0 |
0.1 |
GO:1903935 |
response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
| 0.0 |
0.1 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.0 |
0.1 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.0 |
0.2 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.0 |
0.1 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.0 |
0.1 |
GO:0033512 |
L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.0 |
0.1 |
GO:1903751 |
regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.0 |
0.4 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.0 |
0.1 |
GO:0006939 |
smooth muscle contraction(GO:0006939) |
| 0.0 |
0.1 |
GO:0046035 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.0 |
0.1 |
GO:0002784 |
antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
| 0.0 |
0.1 |
GO:0006581 |
acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.0 |
0.3 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.0 |
0.3 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.0 |
0.1 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.0 |
0.0 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.0 |
0.1 |
GO:0098746 |
fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.0 |
0.2 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.0 |
0.0 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.0 |
0.2 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.0 |
0.1 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.0 |
0.1 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.0 |
0.4 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.0 |
0.1 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.0 |
0.1 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.0 |
0.2 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.0 |
0.0 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.0 |
0.1 |
GO:2000259 |
positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.0 |
0.1 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.0 |
0.2 |
GO:1902969 |
mitotic DNA replication(GO:1902969) |
| 0.0 |
0.3 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.0 |
0.2 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 |
0.1 |
GO:0044205 |
'de novo' UMP biosynthetic process(GO:0044205) |
| 0.0 |
0.5 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 |
0.2 |
GO:0001781 |
neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
| 0.0 |
0.1 |
GO:0070431 |
nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.0 |
0.1 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.0 |
0.2 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 0.0 |
0.0 |
GO:0072229 |
proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
| 0.0 |
0.1 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.0 |
0.1 |
GO:0046984 |
regulation of hemoglobin biosynthetic process(GO:0046984) |
| 0.0 |
0.3 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.0 |
0.1 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.0 |
0.0 |
GO:0010737 |
protein kinase A signaling(GO:0010737) |
| 0.0 |
0.1 |
GO:0001828 |
inner cell mass cellular morphogenesis(GO:0001828) |
| 0.0 |
0.3 |
GO:0070129 |
regulation of mitochondrial translation(GO:0070129) |
| 0.0 |
0.1 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.0 |
0.1 |
GO:0061015 |
snRNA import into nucleus(GO:0061015) |
| 0.0 |
0.1 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.0 |
0.2 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.0 |
0.2 |
GO:2001205 |
negative regulation of osteoclast development(GO:2001205) |
| 0.0 |
0.0 |
GO:0021626 |
hindbrain maturation(GO:0021578) cerebellum maturation(GO:0021590) central nervous system maturation(GO:0021626) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
| 0.0 |
0.1 |
GO:0072579 |
molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.0 |
0.1 |
GO:0060467 |
negative regulation of fertilization(GO:0060467) |
| 0.0 |
0.1 |
GO:0044053 |
translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.0 |
1.7 |
GO:0050911 |
detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 |
0.1 |
GO:0017198 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.0 |
0.2 |
GO:0035494 |
SNARE complex disassembly(GO:0035494) |
| 0.0 |
0.2 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.0 |
0.1 |
GO:0090095 |
regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.0 |
0.2 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.0 |
0.1 |
GO:0014820 |
tonic smooth muscle contraction(GO:0014820) |
| 0.0 |
0.1 |
GO:0006490 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.0 |
0.1 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.0 |
0.1 |
GO:0048867 |
ganglion mother cell fate determination(GO:0007402) stem cell fate determination(GO:0048867) |
| 0.0 |
1.2 |
GO:1901016 |
regulation of potassium ion transmembrane transporter activity(GO:1901016) |
| 0.0 |
0.1 |
GO:2000409 |
positive regulation of T cell extravasation(GO:2000409) positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) |
| 0.0 |
0.1 |
GO:0071030 |
nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
| 0.0 |
0.4 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.0 |
0.0 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.0 |
0.1 |
GO:0002933 |
lipid hydroxylation(GO:0002933) |
| 0.0 |
0.1 |
GO:0035936 |
testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.0 |
0.2 |
GO:0032071 |
regulation of endodeoxyribonuclease activity(GO:0032071) |
| 0.0 |
0.5 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.0 |
0.0 |
GO:0009080 |
alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.0 |
0.1 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.0 |
0.1 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.0 |
0.1 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.0 |
0.0 |
GO:0060629 |
regulation of homologous chromosome segregation(GO:0060629) |
| 0.0 |
0.0 |
GO:0032640 |
tumor necrosis factor production(GO:0032640) regulation of tumor necrosis factor production(GO:0032680) |
| 0.0 |
0.0 |
GO:2001202 |
regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) negative regulation of transforming growth factor-beta secretion(GO:2001202) |
| 0.0 |
0.1 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.0 |
0.1 |
GO:0034627 |
'de novo' NAD biosynthetic process(GO:0034627) |
| 0.0 |
0.2 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.0 |
0.0 |
GO:0051389 |
inactivation of MAPKK activity(GO:0051389) |
| 0.0 |
0.1 |
GO:0051122 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.0 |
0.1 |
GO:0043328 |
protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.0 |
0.6 |
GO:0019184 |
nonribosomal peptide biosynthetic process(GO:0019184) |
| 0.0 |
0.0 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.0 |
0.2 |
GO:0048514 |
blood vessel morphogenesis(GO:0048514) |
| 0.0 |
0.2 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.0 |
0.2 |
GO:0019896 |
axonal transport of mitochondrion(GO:0019896) |
| 0.0 |
0.1 |
GO:1901569 |
leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.0 |
0.4 |
GO:0042789 |
mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.0 |
0.3 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.0 |
0.1 |
GO:1901073 |
N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.0 |
0.8 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 |
0.0 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.0 |
0.0 |
GO:0035552 |
oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.0 |
0.1 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.0 |
0.3 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 |
0.1 |
GO:0032455 |
nerve growth factor processing(GO:0032455) |
| 0.0 |
0.1 |
GO:0046618 |
drug export(GO:0046618) |
| 0.0 |
0.0 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.0 |
0.0 |
GO:0051410 |
detoxification of nitrogen compound(GO:0051410) |
| 0.0 |
0.0 |
GO:0051168 |
nuclear export(GO:0051168) |
| 0.0 |
0.9 |
GO:0000281 |
mitotic cytokinesis(GO:0000281) |
| 0.0 |
0.1 |
GO:0044376 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.0 |
0.4 |
GO:0006295 |
nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.0 |
0.0 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.0 |
0.1 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.0 |
0.0 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.0 |
0.1 |
GO:0090002 |
establishment of protein localization to plasma membrane(GO:0090002) |
| 0.0 |
0.1 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.0 |
0.5 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 |
0.0 |
GO:0015993 |
molecular hydrogen transport(GO:0015993) |
| 0.0 |
0.1 |
GO:0045794 |
negative regulation of cell volume(GO:0045794) |
| 0.0 |
0.1 |
GO:0001180 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.0 |
0.0 |
GO:1903568 |
negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.0 |
0.1 |
GO:0061551 |
cranial ganglion development(GO:0061550) trigeminal ganglion development(GO:0061551) |
| 0.0 |
0.1 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.0 |
0.1 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.0 |
0.1 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.0 |
0.3 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.0 |
0.1 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.0 |
0.2 |
GO:0070257 |
positive regulation of mucus secretion(GO:0070257) |
| 0.0 |
0.1 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) |
| 0.0 |
0.1 |
GO:0045329 |
carnitine biosynthetic process(GO:0045329) |
| 0.0 |
0.1 |
GO:1902177 |
positive regulation of integrin biosynthetic process(GO:0045726) positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.0 |
0.1 |
GO:0036343 |
psychomotor behavior(GO:0036343) |
| 0.0 |
0.1 |
GO:0046813 |
receptor-mediated virion attachment to host cell(GO:0046813) |
| 0.0 |
0.0 |
GO:1902544 |
regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.0 |
0.1 |
GO:0006664 |
glycolipid metabolic process(GO:0006664) liposaccharide metabolic process(GO:1903509) |
| 0.0 |
0.0 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.0 |
0.1 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.0 |
0.1 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.0 |
0.1 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.0 |
0.0 |
GO:0071262 |
regulation of eIF2 alpha phosphorylation by amino acid starvation(GO:0060733) regulation of translational initiation in response to starvation(GO:0071262) positive regulation of translational initiation in response to starvation(GO:0071264) |
| 0.0 |
0.1 |
GO:1904977 |
lymphatic endothelial cell migration(GO:1904977) |
| 0.0 |
0.1 |
GO:0034144 |
negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.0 |
0.2 |
GO:1904896 |
ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.0 |
0.1 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.0 |
0.2 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.1 |
GO:0034374 |
low-density lipoprotein particle remodeling(GO:0034374) |
| 0.0 |
0.0 |
GO:1904617 |
negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.0 |
0.1 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.0 |
0.5 |
GO:0050855 |
regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.0 |
0.1 |
GO:0061146 |
Peyer's patch morphogenesis(GO:0061146) |
| 0.0 |
0.2 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 |
0.0 |
GO:0002901 |
mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) regulation of mast cell cytokine production(GO:0032763) positive regulation of mast cell cytokine production(GO:0032765) |
| 0.0 |
0.0 |
GO:0001207 |
histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 0.0 |
0.0 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.0 |
0.1 |
GO:0070863 |
regulation of protein exit from endoplasmic reticulum(GO:0070861) positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.0 |
0.0 |
GO:2000645 |
negative regulation of receptor catabolic process(GO:2000645) |
| 0.0 |
0.1 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.0 |
0.5 |
GO:0051437 |
positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition(GO:0051437) |
| 0.0 |
0.0 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.0 |
0.1 |
GO:0048102 |
autophagic cell death(GO:0048102) response to odorant(GO:1990834) |
| 0.0 |
0.0 |
GO:1904116 |
response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.0 |
0.2 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.0 |
0.5 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.0 |
0.0 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.0 |
0.1 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 |
0.1 |
GO:0001705 |
ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.0 |
0.3 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
0.4 |
GO:0035338 |
long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.0 |
0.0 |
GO:0070681 |
glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.0 |
0.1 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 0.0 |
0.0 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) fungiform papilla development(GO:0061196) fungiform papilla morphogenesis(GO:0061197) fungiform papilla formation(GO:0061198) |
| 0.0 |
0.1 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.0 |
0.0 |
GO:0000393 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.0 |
0.1 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.0 |
0.1 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.0 |
0.0 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 0.0 |
0.0 |
GO:0007343 |
egg activation(GO:0007343) |
| 0.0 |
0.1 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.0 |
0.5 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.0 |
0.1 |
GO:0045229 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.0 |
0.1 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.0 |
0.1 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.0 |
0.1 |
GO:0046092 |
deoxycytidine metabolic process(GO:0046092) |
| 0.0 |
0.0 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) |
| 0.0 |
0.1 |
GO:0050955 |
thermoception(GO:0050955) |
| 0.0 |
0.0 |
GO:0016260 |
selenocysteine biosynthetic process(GO:0016260) |
| 0.0 |
0.1 |
GO:0033123 |
positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.0 |
0.2 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.0 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.0 |
0.3 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.0 |
0.1 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.0 |
0.2 |
GO:0038007 |
netrin-activated signaling pathway(GO:0038007) |
| 0.0 |
0.1 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.0 |
0.2 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.0 |
0.0 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.0 |
0.1 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.0 |
0.2 |
GO:0036109 |
alpha-linolenic acid metabolic process(GO:0036109) |
| 0.0 |
1.7 |
GO:0002223 |
stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.0 |
0.1 |
GO:0021953 |
central nervous system neuron differentiation(GO:0021953) |
| 0.0 |
0.0 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.0 |
0.2 |
GO:1904872 |
regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
| 0.0 |
0.1 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.0 |
0.6 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 |
0.1 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.0 |
0.2 |
GO:0045920 |
negative regulation of exocytosis(GO:0045920) |
| 0.0 |
0.0 |
GO:0001909 |
leukocyte mediated cytotoxicity(GO:0001909) |
